// App-Quantinova.ai

4002 : Enhancing the antitumor efficacy of immunotherapy by using the topoisomerase I inhibitor MM398

Researchers

Presenter

  • Jodi A. McKenzie

Principal Investigators

  • Rina M. Mbofung

  • Shruti Malu

  • Rodabe N. Amaria

  • Richard E. Davis

  • Li Zhang

  • Trang N. Tieu

  • Tim P. Heffernan

  • Patrick Hwu

Medical Centers

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Skin carcinoma

  • Melanoma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Anti-CTLA4

  • Irinotecan sucrosofate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved